NIAID/DMID/CASG Central Unit — Birmingham, Alabama

NIAID/DMID/CASG Central Unit is a clinical research site located in Birmingham, Alabama, United States 35294.

Crixeo Health Trust Score: 59/100 (POOR). This profile has not yet been claimed by the site owner.

NIAID/DMID/CASG Central Unit has participated in 3 clinical trials.

Therapeutic areas: Hantavirus Pulmonary Syndrome, Papilloma, Cytomegalovirus Infections.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 59/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NIAID/DMID/CASG Central Unit?

NIAID/DMID/CASG Central Unit has a Crixeo Trust Score of 59/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NIAID/DMID/CASG Central Unit conducted?

NIAID/DMID/CASG Central Unit has 3 clinical trials on record. Their work covers Hantavirus Pulmonary Syndrome, Papilloma, Cytomegalovirus Infections.

Is NIAID/DMID/CASG Central Unit accredited by Crixeo Health?

NIAID/DMID/CASG Central Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NIAID/DMID/CASG Central Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.